Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Transplant Proc ; 46(5): 1430-1, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24935309

ABSTRACT

BACKGROUND: Cell Saver (CS; Haemonemic Corp, Braintree, Mass, United States) is frequently used to decrease transfusion requirements of homologous blood during liver transplantation (OLT). However, the use of CS in hepatitis C virus (HCV)-infected recipients is still debated owing to the potential elevation of HCV RNA level. In this study, we compared HCV RNA levels of CS blood with a series of blood samples obtained from HCV-infected OLT recipients. METHODS: Twelve HCV-infected patients with >50,000 copies/mL of HCV RNA were enrolled. HCV RNA was measured immediately after induction (I), at the end of anhepatic period (II), at the end of operation (III), and from the first returned blood in CS (CSb). HCV RNA level at each time period was compared. RESULTS: HCV RNA levels ranged from 77,931 to 9,072,000 copies/mL at I. When compared to I, HCV RNA levels were reduced to 11.1% ± 13.0% and 0.7% ± 1.0% at II and III, respectively. Also, the RNA level reduced to 3.0% ± 2.0% of I after CS processing. The HCV RNA level at I was significantly higher than the levels at II, III, and CSb (P = .012, each), and the level at II was significantly higher than the level at III (P = .012). The HCV RNA level at CSb showed no statistical difference with the levels at II, but it was significantly higher than the level at III (P = .042). CONCLUSIONS: The use of CS in HCV-infected OLT recipients seems to carry no additional risk with respect to intraoperative HCV RNA kinetics.


Subject(s)
Hepacivirus/genetics , Liver Transplantation , Operative Blood Salvage , RNA, Viral/blood , Female , Humans , Intraoperative Care , Male , Middle Aged
2.
Transplant Proc ; 46(3): 709-11, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24767330

ABSTRACT

BACKGROUND: Graft-recipient weight ratio (GRWR) is the only documented predictor that influences the lactate elimination after reperfusion in living-donor liver transplantation (LDLT). This study was performed to investigate the predictors of lactate elimination after reperfusion in recipients of adult LDLT. METHODS: The medical records of 159 patients who underwent LDLT were analyzed. Lactate level (mmol/L) was measured from just before the initiation of surgery (P0) and 5, 60, and 120 minutes after reperfusion of graft (R0, R1, and R2, respectively). The change of lactate level after reperfusion was defined as difference between lactate level measured at R0 and R2. Patients were divided into accumulation and elimination groups. Donor and recipient factors were compared between the 2 groups. RESULTS: Lactate accumulation occurred in 80 of 159 recipients (50.3%), and elimination occurred in 79 (49.7%). GRWR and Model for End-Stage Liver Disease (MELD) score were higher in the elimination group. Lactate at R0 was lower in the elimination group. CONCLUSIONS: Higher GRWR and MELD score and lower lactate level immediate after reperfusion of graft were predictors of lactate elimination after reperfusion during adult LDLT.


Subject(s)
Lactates/metabolism , Liver Transplantation , Living Donors , Female , Humans , Male , Middle Aged
3.
Vet Pathol ; 47(1): 137-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20080494

ABSTRACT

Spontaneous basal cell carcinoma (BCC) is very rare in rats, with an incidence rate of only 0.14% reported in aged animals. A spontaneous BCC occurred in a 7-week-old Sprague-Dawley rat housed in a specific-pathogen-free animal facility. The tumor was a single, well-delineated reddish-brown subcutaneous mass measuring 2 x 2 cm and located in the left inguinal region. Microscopically, the tumor consisted of basaloid cells in lobular and cribriform growth patterns and with a high mitotic rate. Immunohistochemically, cytokeratin 14 (an indicator for basal keratinocytes of the epidermis) showed strong reactions throughout the whole tumor, and cytokeratin 18 showed weak but positive reaction in the majority of nested tumor cells. To the authors' knowledge, this is the first report of spontaneous BCC occurrence in young Sprague-Dawley rats.


Subject(s)
Carcinoma, Basal Cell/veterinary , Rodent Diseases/pathology , Animals , Carcinoma, Basal Cell/pathology , Keratin-14/metabolism , Male , Mitotic Index/veterinary , Rats , Rats, Sprague-Dawley
4.
Tumour Biol ; 30(5-6): 300-9, 2009.
Article in English | MEDLINE | ID: mdl-19940551

ABSTRACT

BACKGROUND/AIMS: Spheroid cells which can grow as nonattached spheroids in vitro culture condition are considered as tumor-initiating cells that have properties similar to those of stem cells. However, the existence of spheroid cells in WM-266-4, a human malignant metastatic melanoma cell line, has not yet been reported. METHODS: Accordingly, we investigated whether WM-266-4 can form spheroids, and characterized these spheroids using qRT-PCR, histology, immunohistochemistry and xenograft. RESULTS: WM-266-4 contains a small subpopulation of cells that grow as spheroids and express genes strongly related to tumor malignancy and stem-like factors. Second, histological analysis of the spheres revealed that they consist of 300-400 round cells per sphere with a high karyoplasmic ratio. They have a basophilic cytoplasm and are highly pleomorphic in size, and sometimes multinucleated and giant. Third, although there were differences between the spheroid and bulk cells, they both have high tumorigenic potential, as both cell types formed a tumor mass upon injection of only 100 cells in nude mice. CONCLUSION: We characterized the spheroid cells in an established melanoma cell line. We suggest that enriched spheroid cells might contain more dedifferentiated progenitor cells, but we could not conclude spheroid cells are cancer stem cells.


Subject(s)
Melanoma, Experimental/pathology , Melanoma/pathology , Spheroids, Cellular/pathology , AC133 Antigen , ATP Binding Cassette Transporter, Subfamily G, Member 2 , ATP-Binding Cassette Transporters/genetics , Animals , Antigens, CD/genetics , Antigens, Neoplasm/analysis , Biomarkers, Tumor/analysis , Cell Line, Tumor , Cell Proliferation , Female , Gene Expression Regulation, Neoplastic , Glycoproteins/genetics , Homeodomain Proteins/genetics , Humans , Immunohistochemistry , Intermediate Filament Proteins/analysis , Intermediate Filament Proteins/genetics , MART-1 Antigen , Melanoma/genetics , Melanoma/metabolism , Melanoma, Experimental/genetics , Melanoma, Experimental/metabolism , Mice , Mice, Nude , Neoplasm Proteins/analysis , Neoplasm Proteins/genetics , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/genetics , Nestin , Nuclear Proteins/genetics , Peptides/genetics , Polycomb Repressive Complex 1 , Proto-Oncogene Proteins/genetics , Repressor Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Spheroids, Cellular/metabolism , Time Factors , Transplantation, Heterologous , Tumor Burden , Tumor Suppressor Proteins/genetics , Vascular Endothelial Growth Factor Receptor-3/genetics , Wnt Proteins/genetics , Wnt-5a Protein
5.
Eur J Clin Microbiol Infect Dis ; 27(4): 315-9, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18188616

ABSTRACT

Chemotherapy is often futile in systemic listeriosis, translating to being a peril to public health. There is, thus, an imperative need for novel antilisterial compounds, possibly acting through mechanisms dissimilar to those of existing drugs. The present study describes one such agent-the non-steroidal anti-inflammatory drug (NSAID) diclofenac sodium (Dc). The National Committee for Clinical Laboratory Standards (NCCLS) minimum inhibitory concentration (MIC), mode of action, and two mechanisms of action, i.e., on bacterial DNA and membrane, have been characterized with respect to Dc. The drug showed noteworthy inhibitory action (MIC90 = 50 microg/ml) against Listeria strains, demonstrated cidal (minimum bactericidal concentration [MBC]=100 microg/ml) activity, inhibited listerial DNA synthesis (45.48%; incorporation of [methyl-3H] thymidine), and possessed bacterial membrane-damaging activity (37.33%; BacLight assay). Dc could be used as a lead compound for the synthesis of new, more active agents perhaps devoid of side effects. Further, quantitative structure-activity relationship (QSAR) studies will contribute to a new generation of promising adjuvants to existing antilisterial drugs.


Subject(s)
Anti-Bacterial Agents/pharmacology , Diclofenac/pharmacology , Listeria monocytogenes/drug effects , Dose-Response Relationship, Drug , Microbial Sensitivity Tests , Time Factors
6.
Article in English | MEDLINE | ID: mdl-15876223

ABSTRACT

A total of 160 Staphylococcus intermedius isolates were recovered from cases of pyoderma in 2002 and were examined for susceptibility to 13 different antimicrobial agents. Ninety per cent (144) of the isolates were resistant to tetracycline, derivatives of which have been used until recently, and 18% (29) were resistant to chloramphenicol which was banned from use 13 years ago. The presence of genes encoding chloramphenicol acetyltransferase (CAT) and tetracycline resistance (tet); tet(K), (L), (M), and (O) were determined by PCR in the 29 chloramphenicol and tetracycline resistant isolates. Seventeen (59%) isolates contained the cat gene while 12 (41%) isolates did not carry the cat gene, implying there may be other genes for chloramphenicol resistance that were not detected by the primers (primer set 1) used in this study. The tet(M) gene was found in 28 (97%) of the resistant S. intermedius isolates, but none contained the tet(O) gene. All 29 isolates carried one or two tet genes; tet(K), (L), and (M), with four different distribution patterns. New PCR products, a 1.1 kb product using primer set 1 and a 0.2 kb product using primer set 2, were cloned and sequenced. A 904 bp fragment of S. aureus plamid pS194, including sequence from the streptomycin adenyltransferase gene (804 bp), was found inserted into the terminal region of the cat gene (GenBank accession no. AY604739), whilst the sequence of 0.2 kb was previously unpublished.


Subject(s)
Anti-Bacterial Agents/pharmacology , Chloramphenicol/pharmacology , Dog Diseases/microbiology , Pyoderma/veterinary , Staphylococcus/drug effects , Tetracycline/pharmacology , Animals , Base Sequence , Chloramphenicol O-Acetyltransferase/genetics , Dog Diseases/drug therapy , Dogs , Drug Resistance, Bacterial/genetics , Microbial Sensitivity Tests , Molecular Sequence Data , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/veterinary , Pyoderma/drug therapy , Pyoderma/microbiology , Tetracycline Resistance/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...